MPMaksim B. Polianskii

Maksim B. Polianskii

*This is an algorithmically generated author record based on publicly available information.

Maksim B. Polianskii has a total of 12 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    The molecular basis of thyroid status formation and its role in the initiation and promotion of gastric and colorectal cancer: A review

    by Irina V. Stanoevich, Vitaliy A. Ioutsi, Natalya L. Lysovolenko, Ilya E. Alekseev, Alina D. Kondrashkina, Maksim B. Polyansky, Ekaterina V. Pis'MEnnaia

    The concept of thyroid status is much broader than assessing the levels of thyroid stimulating hormone, free and bound thyroid hormones in the systemic circulation. It includes features of transport, tissue bioavailability, receptor interaction, metabolism, biomolecular mechanisms of action and inactivation, as well as the physiological or pathophysiological basis of changes in function and the pathomorphological substrate of diseases, including malignancies. Therefore, the question of the mechanisms through which thyroid status influences the processes of tumor initiation and promotion in the gastrointestinal tract is extremely relevant. Regarding colorectal cancer, an ambiguous link between thyroid status has been identified – in some studies, an increase in free T4 concentration and thyrotoxicosis are associated with a decreased risk of developing colon cancer, while in others, the administration of levothyroxine in hypothyroidism had a protective effect. The risk of gastric cancer is elevated in men living in regions with suboptimal or above-normal iodine consumption and suffering from various thyroid pathologies. This paper analyzes modern ideas about pathogenetic relationship between gastric and colon cancer and patients' thyroid status. It presents physiological and biochemical basics of thyroid status formation. Deiodinase expression profile in gastric and colon cancer is stated. The problem of iodine-induced disthyroidoses following radiation procedures using iodine-containing contrasts is described in detail.

  • Open Access

    Cardiovascular toxicity of chemotherapy and thyroid status of patients with gastric and colon cancer: Current state of the problem. A review

    by Irina V. Stanoevich, Vitaliy A. Ioutsi, Natalya L. Lysovolenko, Ilya E. Alekseev, Alina D. Kondrashkina, Maksim B. Polianskii, Ekaterina V. Pis'MEnnaia

    Cardiovascular and oncological diseases are the main causes of disability and mortality in Russia, sharing common risk factors and exacerbating each other. The specific toxicological effects of fluoropyrimidines, platinum drugs, and taxanes commonly used in the treatment of gastric and colorectal malignancies have been noted to potentially contribute to the onset of cardiovascular pathologies in some cases. However, the manifestation and prevalence of cardiovascular toxicity due to cancer treatment regimens are influenced by various factors beyond just the chemotherapy protocols employed. Gender, age, overall health status (including cardiac and thyroid functions), and other risk factors play significant roles in the development and progression of heart and vascular diseases in these patients. Thyroid dysfunction, even in the absence of severe clinical symptoms, can significantly impact the course of cardiovascular pathologies, complicating the management of toxic effects associated with polychemotherapy on both the cardiac muscle and vascular system. This paper analyzes modern ideas about pathogenetic relationship between cardiovascular diseases and gastric and colon cancer. The profile and mechanism of cardiovascular toxicity of chemotherapy in patients with gastric and colon cancer, pathogenetic relationship of thyroid status and cardiovascular diseases are presented. Organizational management issues of chemotherapy toxicity are briefly highlighted.

  • Morphological and molecular genetic features of gastric cancer

    by E.N. Grebenkin, M.B. Polyanskii, A.N. Perepelevskii, A.S. Mazalova, M.V. Temirbulatov

    High incidence, poor prognosis, risk of progression after radical surgical treatment, cellular and molecular genetic heterogeneity of gastric cancer represent a serious health problem worldwide; the annual death rate is more than 700.000 cases. Understanding oncogenesis, risk factors, and the use of new approaches to treating this pathology are priority tasks of modern oncology. This review is devoted to modern ideas about carcinogenesis, assessment of the morphologically unchanged gastric mucosa through the prism of the precancerous Correa cascade. The basic molecular mechanisms and signaling pathways of carcinogenesis are described, and the tumor microenvironment is characterized.

  • Open Access

    Castleman disease. A rare clinical case of retroperitoneal tumor localization in an elderly patient

    by M. B. Polyanskiy, I. N. Zvyagin, V. A. Petrik, M. V. Temirbulatov

    Castleman disease is an extremely rare benign disease of the lymphatic system with an estimated incidence of 1–9 cases per 1,000,000. Its etiology remains unknown; interleukin 6 (IL-6) plays an important role in pathogenesis. Castleman disease has two clinical forms: localized (up to 90 % of cases) with a favorable prognosis, treated predominantly by surgical method; generalized (up to 10 % of cases) with less favorable prognosis, treated by pharmacological therapy. The diagnosis is rarely established at the preoperative stage.The aim. To present a clinical case of diagnosis and treatment of Castleman tumor of a rare topical localization.Results. A 66-year-old patient was admitted at the Abdominal Oncology Department of the G.E. Ostroverkhov Kursk Oncology Scientific and Clinical Center.Diagnosis: Retroperitoneal mass on the right found at the preventive examination; no peripheral lymphadenopathy was detected on ultrasound and computed tomography (CT). After the examination, a preliminary diagnosis was made: Gastrointestinal stromal tumor (GIST) of the small intestine mesentery. Based on the results of the case conference, the decision was taken to perform a surgery – laparoscopic removal of the tumor under endotracheal anesthesia. For surgical approach, a fan-shaped arrangement of ports was chosen. The surgery had no complications. Intraoperative blood loss was 50.0 ml. The total operating time was 98 minutes.According to the results of the histological study, the following diagnosis was made: Castleman disease, unicentric form, hyaline-vascular variant. En bloc surgery is the standard method for the treatment of localized forms of the Castleman disease. In all cases, long-term follow-up shows a long relapse-free period in almost all patients.During follow-up examinations (ultrasound of the abdominal cavity and retroperitoneal space, CT of the abdominal cavity with contrast enhancement, CT of the chest), no disease recurrence was detected during the year of observation.Castleman disease is a rare non-clonal lymphoproliferative disease of unknown etiology. A rare case of its retroperitoneal localization indicates that in cases with an uncertain nature of the peritoneal mass, Castleman disease should be included in the differential diagnostic search.